You have no items in your shopping cart.
All Products
Recombinant Human PDYN (C-6His) [orb2994893]Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.3 KDa. Observed: 35 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Recombinant Human IGSF11 (C-Fc) [orb2994894]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 50.7 KDa. Observed: 55-70 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human HVEM (C-Fc) [orb2994895]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 44.5 KDa. Observed: 50-60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human Galectin 9 (C-6His) [orb2994896]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 36.7 KDa. Observed: 49 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human TREM-2 (C-6His) [orb2994897]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 18.3 KDa. Observed: 22-40 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human PRPS2 (C-6His) [orb2994898]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 35.8 KDa. Observed: 37 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human MPZ (C-6His) [orb2994899]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.2 KDa. Observed: 14-17 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human Serpin H1 (C-6His) [orb2994900]
Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 45.5 KDa. Observed: 51 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human ANGPTL8 (N-Fc) [orb2994901]
Greater than 70% as determined by reducing SDS-PAGE.
Predicted: 46 KDa. Observed: 54 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human S100A9 [orb2994902]
Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 13.2 KDa. Observed: 14 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg